Celcuity Inc.(CELC)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Pending next ranking run
This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
CELC Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for Celcuity Inc. (CELC), a Healthcare sector company. CELC is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q2 2026), Celcuity Inc. reports net income of $-78.9M, free cash flow of $-55.5M. Top institutional holders of CELC by reported 13-F value include BAKER BROS. ADVISORS, Avoro Capital Advisors, RTW INVESTMENTS, based on the most recent SEC filings. CELC trades on the Nasdaq exchange and files with the SEC under CIK 1603454. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CELC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Celcuity Inc. directly from SEC EDGAR.
Net Income
Q2 2026
$-78.9M
Free Cash Flow
Q2 2026
$-55.5M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProNet Income
-58.4% YoYOperating Income
-52.0% YoYEPS (Diluted)
-33.9% YoYTotal Assets
+90.3% YoYTotal Debt
+30.9% YoYOp. Cash Flow
-83.6% YoYFree Cash Flow
-83.4% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Net Income | $-177.0M -58.4% | $-111.8M -75.3% | $-63.8M -58.0% | $-40.4M -36.4% | $-29.6M -212.5% | $-9.5M |
| Operating Income | $-172.2M -52.0% | $-113.3M -71.0% | $-66.2M -68.1% | $-39.4M -38.9% | $-28.4M -196.7% | $-9.6M |
| EPS (Diluted) | $-3.79 -33.9% | $-2.83 -5.2% | $-2.69 -1.9% | $-2.64 | — | — |
| Total Assets | $466.6M +90.3% | $245.1M +28.2% | $191.2M +8.8% | $175.7M +104.5% | $85.9M +563.0% | $13.0M |
| Total Debt | $137.5M +30.9% | $105.1M +179.8% | $37.6M +5.1% | $35.8M +123.8% | $16.0M | — |
| Operating Cash Flow | $-153.3M -83.6% | $-83.5M -55.1% | $-53.8M -49.4% | $-36.0M -77.3% | $-20.3M -184.3% | $-7.1M |
| Free Cash Flow | $-153.5M -83.4% | $-83.7M -55.3% | $-53.9M -49.1% | $-36.2M -77.3% | $-20.4M -181.9% | $-7.2M |
Get alerted when CELC's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Celcuity Inc. including:
Top Institutional Holders of CELC
BAKER BROS. ADVISORS LP
$828.2M7,915,792 shAvoro Capital Advisors LLC
$355.7M3,400,000 shRTW INVESTMENTS, LP
$345.8M3,304,903 shPERCEPTIVE ADVISORS LLC
$334.5M3,197,200 shBlackRock, Inc.
$315.8M3,018,785 shLINDEN ADVISORS LP
$254.5M112,901,000 shSTATE STREET CORP
$204.6M1,955,304 shVANGUARD CAPITAL MANAGEMENT LLC
$196.1M1,874,137 shNEA Management Company, LLC
$179.0M1,710,561 shSoleus Capital Management, L.P.
$178.3M1,704,318 sh
| Fund | Value | Shares |
|---|---|---|
| BAKER BROS. ADVISORS LP | $828.2M | 7,915,792 |
| Avoro Capital Advisors LLC | $355.7M | 3,400,000 |
| RTW INVESTMENTS, LP | $345.8M | 3,304,903 |
| PERCEPTIVE ADVISORS LLC | $334.5M | 3,197,200 |
| BlackRock, Inc. | $315.8M | 3,018,785 |
| LINDEN ADVISORS LP | $254.5M | 112,901,000 |
| STATE STREET CORP | $204.6M | 1,955,304 |
| VANGUARD CAPITAL MANAGEMENT LLC | $196.1M | 1,874,137 |
| NEA Management Company, LLC | $179.0M | 1,710,561 |
| Soleus Capital Management, L.P. | $178.3M | 1,704,318 |
More Healthcare Companies
View all Healthcare →Put CELC on your watchlist
Track score changes the day Celcuity Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is CELC a good stock to buy?
13F Pro's AI-powered analysis of Celcuity Inc. (CELC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CELC are available on the CELC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. CELC is classified as a mid company.
Which hedge funds own CELC?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CELC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Celcuity Inc.'s investment landscape.